Altered reward processing in the orbitofrontal cortex and hippocampus in healthy first-degree relatives of patients with depression

Psychological Medicine

Volumn 44, Issue 6, 2014, Pages 1183-1195

  Macoveanu, J ^a,b   Knorr, U ^b   Skimminge, A ^a   Sondergaard M G ^b   Jorgensen A ^b   Fauerholdt Jepsen, M ^b   Paulson, O B ^a,b   Knudsen, G M ^b   Siebner, H R ^a,b   Kessing, L V ^b  

^a HVIDOVRE HOSPITAL   (Denmark)

^b University of Copenhagen   (Denmark)

Author keywords

Decision making; depression; escitalopram; pharmacological MRI; reward; SSRI

Indexed keywords

CITALOPRAM; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ADULT; CONTROLLED STUDY; DEPRESSIVE DISORDER, MAJOR; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; FAMILY; FEMALE; GENETIC PREDISPOSITION; GENETICS; HIPPOCAMPUS; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; RANDOMIZED CONTROLLED TRIAL; REWARD; TREATMENT OUTCOME;

ADULT; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PLACEBOS; PREFRONTAL CORTEX; REWARD; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 84903618047     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291713001815     Document Type: Article

References (48)

1. Anderson IM, Juhasz G, Thomas E, Downey D, McKie S, Deakin JFW, Elliott R (2011). The effect of acute citalopram on face emotion processing in remitted depression: a pharmacoMRI study. European Neuropsychopharmacology 21, 140-148.
2. Baaré WFC, Vinberg M, Knudsen GM, Paulson OB, Langkilde AR, Jernigan TL, Kessing LV (2010). Hippocampal volume changes in healthy subjects at risk of unipolar depression. Journal of Psychiatric Research 44, 655-662.
3. Boorman ED, Behrens TE, Rushworth MF (2011). Counterfactual choice and learning in a neural network centered on human lateral frontopolar cortex. PLoS Biology 9, e1001093.
4. Boorman ED, Behrens TEJ, Woolrich MW, Rushworth MFS (2009). How green is the grass on the other side? Frontopolar cortex and the evidence in favor of alternative courses of action. Neuron 62, 733-743.
5. Bylsma LM, Morris BH, Rottenberg J (2008). A meta-analysis of emotional reactivity in major depressive disorder. Clinical Psychology Review 28, 676-691.
6. Carballedo A, Lisiecka D, Fagan A, Saleh K, Ferguson Y, Connolly G, Meaney J, Frodl T (2012). Early life adversity is associated with brain changes in subjects at family risk for depression. World Journal of Biological Psychiatry 13, 569-578.
7. Coryell W, Endicott J, Keller M (1992). Major depression in a nonclinical sample. Demographic and clinical risk factors for first onset. Archives of General Psychiatry 49, 117-125.
8. Deichmann R, Gottfried JA, Hutton C, Turner R (2003). Optimized EPI for fMRI studies of the orbitofrontal cortex. NeuroImage 19, 430-441.
9. Drevets WC (2007). Orbitofrontal cortex function and structure in depression. Annals of the New York Academy of Sciences 1121, 499-527.
10. Drevets WC, Gadde K, Krishnan KRR (2004). Neuroimaging studies of depression. In The Neurobiological Foundation of Mental Illness, 2nd edn (ed. D. S. Charney, E. Nestler and B. J. Bunney), pp. 461-490. Oxford University Press: New York.
11. Femenía T, Gómez-Galán M, Lindskog M, Magara S (2012). Dysfunctional hippocampal activity affects emotion and cognition in mood disorders. Brain Research 1476, 58-70.
12. Frokjaer VG, Vinberg M, Erritzoe D, Svarer C, Baaré W, Budtz-Joergensen E, Madsen K, Madsen J, Kessing LV, Knudsen GM (2009). High familial risk for mood disorder is associated with low dorsolateral prefrontal cortex serotonin transporter binding. NeuroImage 46, 360-366.
13. Glover GH, Li TQ, Ress D (2000). Image-based method for retrospective correction of physiological motion effects in fMRI: RETROICOR. Magnetic Resonance in Medicine 44, 162-167.
14. Goodnick PJ, Goldstein BJ (1998). Selective serotonin reuptake inhibitors in affective disorders: I. Basic pharmacology. Journal of Psychopharmacology 12, S5-S20.
15. Gotlib IH, Hamilton JP, Cooney RE, Singh MK, Henry ML, Joormann J (2010). Neural processing of reward and loss in girls at risk for major depression. Archives of General Psychiatry 67, 380-387.
16. Haastrup E, Knorr U, Erikstrup C, Kessing LV, Ullum H (2012). No evidence for an anti-inflammatory effect of escitalopram intervention in healthy individuals with a family history of depression. Journal of Neuroimmunology 243, 69-72.
17. Hamilton M (1959). The assessment of anxiety states by rating. British Journal of Medical Psychology 32, 50-55.
18. Hamilton M (1980). Rating depressive patients. Journal of Clinical Psychiatry 41, 21-24.
19. Henriques JB, Davidson RJ (2000). Decreased responsiveness to reward in depression. Cognition and Emotion 14, 711-724.
20. Kendler KS, Gardner CO, Prescott CA (1999). Clinical characteristics of major depression that predict risk of depression in relatives. Archives of General Psychiatry 56, 322-327.
21. Knorr U, Vinberg M, Gade A, Winkel P, Gluud C, Wetterslev J, Gether U, Kessing L (2011a). A randomized trial of the effect of escitalopram versus placebo on cognitive function in healthy first-degree relatives of patients with depression. Therapeutic Advances in Psychopharmacology 1, 133-144.
22. Knorr U, Vinberg M, Gether U, Winkel P, Gluud C, Wetterslev J, Kessing LV (2012a). The effect of escitalopram versus placebo on perceived stress and salivary cortisol in healthy first-degree relatives of patients with depression - a randomised trial. Psychiatry Research 200, 354-360.
23. Knorr U, Vinberg M, Hansen A, Klose M, Feldt-Rasmussen U, Hilsted L, Hasselstrøm J, Gether U, Winkel P, Gluud C, Wetterslev J, Kessing LV (2011b). Escitalopram and neuroendocrine response in healthy first-degree relatives to depressed patients - a randomized placebo-controlled trial. PloS One 6, e21224.
24. Knorr U, Vinberg M, Klose M, Feldt-Rasmussen U, Hilsted L, Gade A, Haastrup E, Paulson O, Wetterslev J, Gluud C, Gether U, Kessing L (2009). Rationale and design of the participant, investigator, observer, and data-analyst-blinded randomized AGENDA trial on associations between gene-polymorphisms, endophenotypes for depression and antidepressive intervention: the effect of escitalopram versus placebo on the combined dexamethasone-corticotrophine releasing hormone test and other potential endophenotypes in healthy first-degree relatives of persons with depression. Trials 10, 66.
25. Knorr U, Vinberg M, Mortensen EL, Winkel P, Gluud C, Wetterslev J, Gether U, Kessing LV (2012b). Effect of chronic escitalopram versus placebo on personality traits in healthy first-degree relatives of patients with depression: a randomized trial. PLoS One 7, e31980.
26. Lisiecka DM, Carballedo A, Fagan AJ, Connolly G, Meaney J, Frodl T (2012). Altered inhibition of negative emotions in subjects at family risk of major depressive disorder. Journal of Psychiatric Research 46, 181-188.
27. Liu X, Powell DK, Wang H, Gold BT, Corbly CR, Joseph JE (2007). Functional dissociation in frontal and striatal areas for processing of positive and negative reward information. Journal of Neuroscience 27, 4587-4597.
28. Lund TE, Madsen KH, Sidaros K, Luo W-L, Nichols TE (2006). Non-white noise in fMRI: does modelling have an impact? NeuroImage 29, 54-66.
29. Macoveanu J, Rowe JB, Hornboll B, Elliott R, Paulson OB, Knudsen GM, Siebner HR (2012). Playing it safe but losing anyway: serotonergic signaling of negative outcomes in dorsomedial prefrontal cortex in the context of risk-aversion. European Neuropsychopharmacology. Published online: 7 October 2012. doi:10.1016/j. euroneuro.2012.09.006.
30. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH (2003). An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. NeuroImage 19, 1233-1239.
31. Mannie ZN, Taylor MJ, Harmer CJ, Cowen PJ, Norbury R (2011). Frontolimbic responses to emotional faces in young people at familial risk of depression. Journal of Affective Disorders 130, 127-132.
32. McCabe C, Mishor Z, Cowen PJ, Harmer CJ (2010). Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment. Biological Psychiatry 67, 439-445.
33. McNair PM, Lorr M DL (1971). Profile of Mood States Manual. Educational and Industrial Testing Service: San Diego, CA.
34. O'Doherty JP (2004). Reward representations and reward-related learning in the human brain: insights from neuroimaging. Current Opinion in Neurobiology 14, 769-776.
35. Pizzagalli DA, Iosifescu D, Hallett LA, Ratner KG, Fava M (2008). Reduced hedonic capacity in major depressive disorder: evidence from a probabilistic reward task. Journal of Psychiatric Research 43, 76-87.
36. Robinson OJ, Cools R, Sahakian BJ (2012). Tryptophan depletion disinhibits punishment but not reward prediction: implications for resilience. Psychopharmacology (Berlin) 219, 599-605.
37. Rogers RD, Tunbridge EM, Bhagwagar Z, Drevets WC, Sahakian BJ, Carter CS (2003). Tryptophan depletion alters the decision-making of healthy volunteers through altered processing of reward cues. Neuropsychopharmacology 28, 153-162.
38. Schultz W (1998). Predictive reward signal of dopamine neurons. Journal of Neurophysiology 80, 1-27.
39. Sloan DM, Strauss ME, Wisner KL (2001). Diminished response to pleasant stimuli by depressed women. Journal of Abnormal Psychology 110, 488-493.
40. Smoski MJ, Lynch TR, Rosenthal MZ, Cheavens JS, Chapman AL, Krishnan RR (2008). Decision-making and risk aversion among depressive adults. Journal of Behavior Therapy and Experimental Psychiatry 39, 567-576.
41. Smoski MJ, Rittenberg A, Dichter GS (2011). Major depressive disorder is characterized by greater reward network activation to monetary than pleasant image rewards. Psychiatry Research 194, 263-270.
42. Steele JD, Kumar P, Ebmeier KP (2007). Blunted response to feedback information in depressive illness. Brain: A Journal of Neurology 130, 2367-2374.
43. Sullivan PF, Neale MC, Kendler KS (2000). Genetic epidemiology of major depression: review and meta-analysis. American Journal of Psychiatry 157, 1552-1562.
44. Tao R, Calley CS, Hart J, Mayes TL, Nakonezny PA, Lu H, Kennard BD, Tamminga CA, Emslie GJ (2012). Brain activity in adolescent major depressive disorder before and after fluoxetine treatment. American Journal of Psychiatry 169, 381-388.
45. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M (2002). Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage 15, 273-289.
46. Videbech P, Ravnkilde B (2004). Hippocampal volume and depression: a meta-analysis of MRI studies. American Journal of Psychiatry 161, 1957-1966.
47. Weissman MM, Wickramaratne P, Adams PB, Lish JD, Horwath E, Charney D, Woods SW, Leeman E, Frosch E (1993). The relationship between panic disorder and major depression. A new family study. Archives of General Psychiatry 50, 767-780.
48. Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R, Jablenski A, Regier D, Sartorius N (1990). SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Archives of General Psychiatry 47, 589-593.